Copyright
©The Author(s) 2024.
World J Gastroenterol. Apr 7, 2024; 30(13): 1815-1835
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1815
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1815
Figure 1 Timeline with key milestones in immuno-oncology research and United States Food and Drug Administration–approved immune checkpoint inhibitors in colorectal cancer.
- Citation: Sharma S, Singh N, Turk AA, Wan I, Guttikonda A, Dong JL, Zhang X, Opyrchal M. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions. World J Gastroenterol 2024; 30(13): 1815-1835
- URL: https://www.wjgnet.com/1007-9327/full/v30/i13/1815.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i13.1815